Change Agents Corporation Reports $2.18M Net Loss, Shifts Focus to AI and Consumer Health Technology

Change Agents Corporation reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2026. The company recorded a net loss of $2.18 million for the quarter, a substantial decrease from a loss of $13.46 million in the same period last year, marking an 83.8% improvement. For the first half of 2026, the net loss was $6.66 million, down from $15.94 million in the prior year, reflecting a 58.2% reduction. The company's total revenue from continuing operations remained at zero, as it ceased operations in its laboratory services segment in early 2025.

The financial position of Change Agents Corporation showed a notable decline in total assets, which decreased to $14.72 million from $23.40 million at the end of 2025. Current assets fell sharply to $499,714, down from $1.50 million, primarily due to a significant reduction in receivables from the sale of equity method investments. Current liabilities also decreased to $4.59 million from $14.15 million, largely due to the repayment of various debts and the sale of its subsidiary, Avalon RT 9, which generated a gain of $1.86 million recorded in additional paid-in capital.

Strategically, the company has shifted its focus towards artificial intelligence and consumer health technology. It operates through two segments: an AI software segment, which includes the development of an AI-driven video generation platform, and a consumer health segment that distributes the Keto Air breathalyzer device. The company is also exploring expansion into drone interception technology through a new subsidiary, Autonomous Air Defense Systems LLC. The recent name change from Avalon GloboCare Corp. to Change Agents Corporation, effective July 20, 2026, reflects this strategic pivot.

Operationally, the company has seen a decrease in its employee headcount, which is now at 15, down from 20 in the previous year. The company is actively seeking complementary acquisitions to bolster its AI capabilities and revenue generation. However, it faces challenges, including a working capital deficit of approximately $4.09 million and negative cash flow from operations of $3.56 million for the first half of 2026. The company has indicated that its current cash balance is insufficient to cover operating expenses for the next twelve months, raising concerns about its ability to continue as a going concern.

Looking ahead, Change Agents Corporation plans to raise additional capital through equity sales to support its business operations and growth initiatives. The company acknowledges the uncertainty surrounding its ability to generate sufficient revenue and maintain adequate cash reserves, which are critical for its ongoing operations. The management's outlook remains cautious, emphasizing the need for successful execution of its business plan and the importance of securing financing to ensure future viability.